Regional Health Properties, Inc. (RHEP)
OTCMKTS · Delayed Price · Currency is USD
1.820
-0.030 (-1.62%)
Aug 28, 2025, 3:44 PM EDT
RHEP Market Cap
RHEP has a market cap or net worth of $6.76 million as of August 28, 2025. Its market cap has increased by 77.90% in one year.
Market Cap
6.76M
Enterprise Value
76.53M
Revenue
26.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.82
Market Cap Chart
Since October 2, 2017, RHEP's market cap has decreased from 233.80M to 6.76M, a decrease of -97.11%. That is a compound annual growth rate of -36.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 6.76M | 130.20% |
| Dec 31, 2024 | 2.94M | -17.65% |
| Dec 29, 2023 | 3.57M | -38.01% |
| Dec 30, 2022 | 5.76M | -24.72% |
| Dec 31, 2021 | 7.65M | 27.59% |
| Dec 31, 2020 | 5.99M | 158.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 586.30M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |